Clinical Trends for February 2017

Ryan Syrek


February 24, 2017

Clinical Trend of the Week (February 11 - 17): Pancreatic Cancer

A complex connection with another condition resulted in this week's top search term. A European study of more than 550,000 patients with type 2 diabetes found that receiving glucagonlike peptide-1 (GLP-1) receptor agonists, or insulin mimetics, was associated with an increased risk of developing pancreatic cancer. However, the findings also suggest that the risk diminished rapidly after diagnosis. Additionally, "reverse causation" is a possibility, as asymptomatic pancreatic cancer that initially caused diabetes prior to progressing to a symptomatic state may be at work. Given this complicated association, it's no wonder that the top search term, "pancreatic cancer," was followed by "diabetes" in terms of popularity this week.

For more information on pancreatic cancer, read here.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.